Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model

J Cardiothorac Vasc Anesth. 2013 Dec;27(6):e69-71. doi: 10.1053/j.jvca.2013.06.010. Epub 2013 Oct 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use*
  • Fibrinolytic Agents / therapeutic use
  • Hemodilution / methods*
  • Hemorrhage / chemically induced
  • Humans
  • Perfusion
  • Piperazines / therapeutic use
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prasugrel Hydrochloride
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Receptors, Purinergic P2Y12 / drug effects*
  • Thiophenes / therapeutic use

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Piperazines
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2Y12
  • Thiophenes
  • Prasugrel Hydrochloride